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To the Editor,
Apparent comorbidity between bipolar disorder (BD) and 
anxiety disorders is a common condition in psychiatry with 
higher prevalence rates for generalised anxiety disorder, so-
cial phobia, panic disorder.1
Overlapping clinical criteria for many diagnoses, especially 
mood and anxiety disorders, produced by the Diagnostic and 
Statistical Manual of Mental Disorders (DSM) might lay be-
hind these high prevalence rates.2 Using DSM, it is unclear 
whether concomitant diagnoses actually reflect the presence 
of distinct clinical entities or refer to multiple manifestations of 
a single clinical entity.
With regard to anxiety disorders, one of the most difficult 
additional psychiatric diagnosis to manage in BD patients is 
obsessive-compulsive disorder (OCD).3,4 In our recent meta-
analysis, the pooled prevalence of OCD in BD was 17.0%, 
which was comparable to the results reported by the pooled 
prevalence of BD in OCD (18.35%).5 In line with previous stud-
ies,6 OCD prevalence rate was higher among BD children and 
adolescents (24.2%, compared to 13.5% in adults).
The co-occurrence of symptoms of BD and OCD was noted 
150 years ago by Morel,7 but the topic is insufficiently studied 
and the relationship between BD and OCD remains unclear.
In agreement with Kraepelin’s thought a psychiatric diagno-
sis is best established by its longitudinal course of illness, the 
evidence so far supports the view that, especially among pa-
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tients with a primary diagnosis of BD, the majority of comor-
bid OCD cases appeared to be related to mood episodes.8 OC 
symptoms in comorbid patients appeared more often-and 
sometimes exclusively-during depressive episodes, and co-
morbid BD and OCD cycled together, with OC symptoms of-
ten remitting during manic/hypomanic episodes.
Therefore, only a substantial minority of comorbid BD-
OCD may represent “true” OCD independent of BD with OC 
symptoms that improve or worsen during mood episodes with-
out being related to these.
These findings are in line with Feinstein’s definition of co-
morbidity, as “any distinct additional entity that has existed 
or may occur during the clinical course of a patient who has 
the index disease under study”.2 “True” OCD comorbid with 
BD would represent the random co-occurrence of two inde-
pendent diseases, estimated by multiplication of prevalence 
rates, which are about 1% for each condition, and producing 
a very low expected true comorbidity of 0.1% in the general 
population.
The treatment of BD-OCD patients remains a great chal-
lenge, since the gold standard for one disease (serotonin reup-
take inhibitors for OCD) can worsen the other (antidepres-
sants can cause mania and/or more mood episodes in BD).
The clinical features of comorbid BD-OCD patients would 
explain why OCD and BD symptoms respond to adequate 
mood stabilizer treatment.3 Only in a minority of comorbid 
patients with persistent OCD, despite improvement in mood 
episodes, addition of low doses of antidepressants could be 
considered while strictly monitoring emerging symptoms of 
mania or mixed states. Benefit with antipsychotics was also 
seen, although a few reports also exist of exacerbation of OC 
symptoms with neuroleptic agents.
Considering the growing interest over the last decades into 
shared pathophysiologies across psychiatric disorders, stud-
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ies addressing neurobiological substrates are essential to illu-
minate pathogenetic mechanisms that underlie comorbid BD-
OCD. 
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